Exchange: OTC·Updated 12:08 PM EDT

CFRXQ ContraFect Corp

$0.0001
$0.00
(0.00%)
Today
Mkt Cap$1,070.00
Vol1,316.00

About CFRXQ

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
43

Bearish Sentiment

How do you feel about CFRXQ?

Advertisement|Remove ads.